A Study of IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor
NCT06365840
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
TMB-H
Histologically or Cytologically Proven Metastatic or Locally Advanced Solid Tumors
Interventions
DRUG:
IMC-001
Sponsor
ImmuneOncia Therapeutics Inc.